# China NMPA Product Recall - Medtronic U-clip V100D Anastomosis Device

Source: https://www.globalkeysolutions.net/records/china_product_recall/medtronic-inc/2a769035-9e77-4eee-a47d-1d9a7a9f0351/
Source feed: China

> China NMPA product recall for Medtronic U-clip V100D Anastomosis Device by Medtronic Inc. published May 19, 2010. Recall level: . The National Medical Products Administration (NMPA) oversaw a recall initiated by Medtronic for its 

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Medtronic U-clip V100D Anastomosis Device Recall Event Report Form
- Company Name: Medtronic Inc.
- Publication Date: 2010-05-19
- Product Name: Medtronic U-clip V100D Anastomosis Device
- Recall Reason: During use, the mechanical release component of a certain batch of V100D U-Clip® products detached from the needle. This does not affect the performance of the needle, but may leave the detached mechanical release component in the body.
- Discovering Company: Medtronic
- Manufacturing Company: Medtronic Inc.
- Summary: The National Medical Products Administration (NMPA) oversaw a recall initiated by Medtronic for its U-clip V100D Anastomosis Device, as detailed in a report published on May 19, 2010. This recall involved devices manufactured between April 2005 and March 19, 2010, impacting markets across the USA, Europe, Canada, and the Asia Pacific, with 96 units sold in China. The core issue driving the recall was the detachment of the mechanical release component from the needle during surgical use, specifically when the needle was manipulated or withdrawn from biological tissue. Although the needle's primary function remained operational, this detachment created a risk of the component being unintentionally left within a patient's body. Medtronic identified this issue after receiving five customer complaints in April 2010, indicating a widespread problem affecting 357 batches across 27,276 packages. In response, Medtronic launched a global corrective campaign under the NMPA's guidance. The company committed to informing affected physicians directly about specific corrective measures. Medtronic was also required to report the progress and completion status of this recall effort to the NMPA, with the global campaign expected to conclude by July 9, 2010, to ensure patient safety and address the device's malfunction.

Company: https://www.globalkeysolutions.net/companies/medtronic-inc/398d5f72-c7d2-4c97-94fc-fbef4cf2336d/